Liraglutide for Weight Management in Children and Adolescents With Prader–Willi Syndrome and Obesity

202265 citationsJournal Articlebronze Open Access

Authors

Gwénaëlle Diene

Moris Angulo

Paula M. Hale · Novo Nordisk (United States)

Cecilie H. Jepsen · Novo Nordisk (Denmark)

Paul L. Hofman · University of Auckland

Anita C. S. Hokken‐Koelega · Erasmus MC

Chethana Ramesh · Novo Nordisk (India)

Serap Turan ·

Abstract

Although the coprimary endpoints were not met, changes in hyperphagia total and drive scores in adolescents warrant further studies on liraglutide in this population.

Topics & Keywords

Genetic Syndromes and Imprinting Genetics and Neurodevelopmental Disorders Diabetes Treatment and Management

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The Journal of Clinical Endocrinology & Metabolism

Volume 108, Issue 1, pp. 4-12

DOI: 10.1210/clinem/dgac549

Field-Weighted Citation Impact: 9.96